Inducing Systemic Immunity and Regressions in Metastatic Melanoma

PHASE1CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

July 31, 1978

Primary Completion Date

May 31, 2002

Study Completion Date

May 31, 2002

Conditions
Metastatic Malignant Melanoma
Interventions
BIOLOGICAL

Autologous cytokines

Sterile autologous cytokines were injected weekly into multiple metastatic nodules while other nodules in the patient were never injected and were monitored for the development of dense lymphocytic infiltrates as evidence of an induced immune response.

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT02350972 - Inducing Systemic Immunity and Regressions in Metastatic Melanoma | Biotech Hunter | Biotech Hunter